They show that injecting anti-NMDAR antibodies into the medial prefrontal cortex of mice leads to cognitive impairments and dysfunction of parvalbumin-positive interneurons, mirroring changes observed in humans. The gene discussed is PVALB; the disease is Cognitive impairment.